There has been intensive search for a substance that can have disease-modifying activity for osteoarthritis. A number of medications have been reported to be of benefit on slowing progression of knee OA. This trial will be the first head to head comparison of these medications. Patients aged between age 40 to 65 will be enrolled. Patients will be assessed clinically using two scoring systems, the WOMAC index for knee arthritis and the SF 36 for overall physical and mental health. The knee X rays will be assessed on Kellgren and Lawrence grading and will also be measured for joint space narrowing at follow up. The response to arthritis medications on slowing down cartilage loss will be measured biochemically with COMP levels.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
322
The Indus Hospital
Karachi, Sindh, Pakistan
Change in WOMAC score at 24 months in comparison to baseline score
Hypothesis:- At least one of the intervention drug will result in an improvement of at least 20 points on the WOMAC score at end of 2 years as compared to the placebo when compared to base line score
Time frame: baseline, 24 months
Change to the SF-36 score at 24 months in comparison to baseline score
Hypothesis: At least one of the intervention drugs will result in an improvement of at least 20 points at end of two years when assessed using the SF36 total score as compared to the standard therapy placebo when compared with baseline score
Time frame: 24 months
Mean differences in blood serum COMP levels of study arms
Time frame: 24 months
Change in WOMAC score at 6 months in comparison to baseline score
Time frame: 6 months
Change in WOMAC score at 12 months in comparison to baseline score
Time frame: 12 months
Change in WOMAC score at 18 months in comparison to baseline score
Time frame: 18 months
Change to the SF-36 score at 6 months in comparison to baseline score
Time frame: 6 months
Change to the SF-36 score at 12 months in comparison to baseline score
Time frame: 12 months
Change to the SF-36 score at 18 months in comparison to baseline score
Time frame: 18 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.